Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three months prospective study

Publikation: Bidrag til tidsskriftKommentar/debatForskning

Dokumenter

  • Fulltext

    Forlagets udgivne version, 604 KB, PDF-dokument

OriginalsprogEngelsk
TidsskriftClinical and Experimental Allergy
Vol/bind52
Antal sider4
ISSN0954-7894
DOI
StatusUdgivet - 2022

ID: 300381204